Amphotericin B from Streptomyces species is widely utilized in research focused on:
Antifungal Treatments: This compound is a cornerstone in treating serious fungal infections, particularly in immunocompromised patients, such as those undergoing chemotherapy or with HIV/AIDS.
Pharmaceutical Development: Researchers are continually exploring formulations that enhance the efficacy and reduce the toxicity of Amphotericin B, leading to innovative drug delivery systems.
Veterinary Medicine: It is also used in veterinary practices to treat fungal infections in animals, showcasing its versatility across species.
Research on Drug Resistance: Scientists study Amphotericin B to understand mechanisms of antifungal resistance, which is crucial for developing new therapeutic strategies.
Combination Therapies: This compound is often used in combination with other antifungal agents to improve treatment outcomes and minimize side effects, making it a valuable tool in clinical settings.
